- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01411501
Efficacy and Safety of Acupuncture for Functional Constipation
Efficacy and Safety of Acupuncture for Functional Constipation: a Multi-center Randomized Controlled Trial
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Phase 3
Contacts and Locations
Study Locations
-
-
-
Beijing, China, 100053
- No.5 Beixiange Street, Xuanwu District
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Patients who has been diagnosed with functional constipation according to Rome Ⅲ criteria
- Patients who are aged 18-75 years old
- Stop medication or acupuncture (if any) 1 week before randomization and uninvolved in other trials
- Sign the informed consent out of one's own will
Exclusion Criteria:
- Secondary constipation
- Patients with consciousness impairment, psychotic patients or patients unable to express clearly
- Patients with malignant tumor in progressive stage, severe wasting disease and liable to be infected and bleed
- Patients with severe cardiovascular disease, hepatic injury, renal damage, digestive disease or hematological diseases
- Women in pregnancy and lactation period
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Acupuncture at ST25 and BL25
the points formula of back-shu point combination with front-mu point.
|
Thrust and lift the needle to achieve De Qi. After being needled, the points will be punctured again using auxiliary needles 2 mm lateral to the first needle, and to a depth of 2 mm without manual stimulation. Put the electric stimulator on the pair of needles with a continuous wave, 20Hz. The current intensity is increased to the patients' maximum tolerance and then slightly reduced to a bearable level (0.1-1.0 mA). Huatuo Brand needle (φ0.30×25mm,φ0.30×40mm,φ0.30×50mm, produced by Suzhou Medical Appliance Factory) and G6805-1A electro-acupuncture apparatus(produced by Shanghai Huayi Medical Instrument Co. Ltd.) will be used. Five sessions/week in the first 2 weeks, three sessions/week for in the last 2 weeks.
Other Names:
|
Experimental: Acupuncture at LI11 and ST37
the points formula of He-points
|
Thrust and lift the needle to achieve De Qi. After being needled, the points will be punctured again using auxiliary needles 2 mm lateral to the first needle, and to a depth of 2 mm without manual stimulation. Put the electric stimulator on the pair of needles with a continuous wave, 20Hz. The current intensity is increased to the patients' maximum tolerance and then slightly reduced to a bearable level (0.1-1.0 mA). Huatuo Brand needle (φ0.30×25mm,φ0.30×40mm,φ0.30×50mm, produced by Suzhou Medical Appliance Factory) and G6805-1A electro-acupuncture apparatus(produced by Shanghai Huayi Medical Instrument Co. Ltd.) will be used. Five sessions/week in the first 2 weeks, three sessions/week for in the last 2 weeks.
Other Names:
|
Experimental: Acupuncture at ST25, BL25, LI11 and ST37
the formula of He-point,back-shu point and front-mu point
|
Thrust and lift the needle to achieve De Qi. After being needled, the points will be punctured again using auxiliary needles 2 mm lateral to the first needle, and to a depth of 2 mm without manual stimulation. Put the electric stimulator on the pair of needles with a continuous wave, 20Hz. The current intensity is increased to the patients' maximum tolerance and then slightly reduced to a bearable level (0.1-1.0 mA). Huatuo Brand needle (φ0.30×25mm,φ0.30×40mm,φ0.30×50mm, produced by Suzhou Medical Appliance Factory) and G6805-1A electro-acupuncture apparatus(produced by Shanghai Huayi Medical Instrument Co. Ltd.) will be used. Five sessions/week in the first 2 weeks, three sessions/week for in the last 2 weeks.
Other Names:
|
Active Comparator: medicine
oral use of mosapride citrate
|
4-week oral use of mosapride citrate, 5mg, three times daily 0.5 hour before meal
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change of the SBMs From Baseline at Week 4
Time Frame: baseline and at 4 weeks
|
[average number of spontaneous bowel movements in a week at week 4]-[average number of spontaneous bowel movements in a week at baseline]
|
baseline and at 4 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change From Baseline in the Bristol Stool Scale at the 4th Week
Time Frame: baseline and at 4 weeks
|
Bristol stool scale provides illustration of seven stool types.
It ranges from 1 to 7 with the meaning that 1 referring to separate hard lumps and 7 referring to watery, no solid pieces.
For patients with constipation, a higher score means a better outcome.
This outcome means the Bristol Stool Scale at the 4th week-the Bristol Stool Scale at baseline.
|
baseline and at 4 weeks
|
Change From Baseline in Difficulty Degree of Defecation at the 4th Week
Time Frame: baseline and at 4 weeks
|
This outcome describes how much effort the patients with while defecating.It ranges from 0 to 3. 0-Without difficulty
[the average score of one week at the 4th week]-[the average score of one week at baseline] |
baseline and at 4 weeks
|
Changes of the SBMs From Baseline at Week 8
Time Frame: baseline and at 8 weeks
|
[average number of spontaneous bowel movements in a week at week 8]-[average number of spontaneous bowel movements in a week at baseline]
|
baseline and at 8 weeks
|
Change From Baseline in the Bristol Stool Scale at the 8th Week
Time Frame: baseline and at 8 weeks
|
Bristol stool scale provides illustration of seven stool types.
It ranges from 1 to 7 with the meaning that 1 referring to separate hard lumps and 7 referring to watery, no solid pieces.
For patients with constipation, a higher score means a better outcome.
This outcome means the Bristol Stool Scale at the 8th week-the Bristol Stool Scale at baseline.
|
baseline and at 8 weeks
|
Change From Baseline in Difficulty Degree of Defecation at the 8th Week
Time Frame: baseline and at 8 weeks
|
This outcome describes how much effort the patients with while defecating. It ranges from 0 to 3. 0-Without difficulty
[the average score of one week at the 8th week]-[the average score of one week at baseline] |
baseline and at 8 weeks
|
Collaborators and Investigators
Investigators
- Study Chair: LIU Zhishun, phD, Guang'an Men Hospital Affiliated to China Academy of Chinese Medical Sciences
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Signs and Symptoms, Digestive
- Constipation
- Physiological Effects of Drugs
- Neurotransmitter Agents
- Molecular Mechanisms of Pharmacological Action
- Gastrointestinal Agents
- Serotonin Agents
- Serotonin Receptor Agonists
- Anticoagulants
- Chelating Agents
- Sequestering Agents
- Calcium Chelating Agents
- Mosapride
- Citric Acid
- Sodium Citrate
Other Study ID Numbers
- 2011CB505202
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Constipation
-
usMIMA S.L.CompletedConstipation | Constipation Chronic Idiopathic | Constipation; NeurogenicSpain, United Kingdom
-
AbbVieIronwood Pharmaceuticals, Inc.RecruitingFunctional Constipation (FC) | Chronic Idiopathic Constipation (CIC)United States, United Kingdom, Bulgaria, Netherlands
-
usMIMA S.L.University of York; County Durham and Darlington NHS Foundation TrustNot yet recruitingConstipation | Constipation-predominant Irritable Bowel Syndrome | Constipation - Functional | Constipation Chronic Idiopathic | Constipation; Neurogenic
-
Institute of Medical Sciences and SUM HospitalNot yet recruitingFunctional Constipation | Constipation - Functional | Constipation Chronic Idiopathic | Fecal Impaction | Pediatric Functional ConstipationIndia
-
SK Life Science, Inc.CompletedChronic Constipation | Functional ConstipationUnited States
-
Cairo UniversityUnknownChronic Idiopathic Constipation | Functional ConstipationEgypt
-
ProgenaBiomeRecruitingConstipation | Constipation - Functional | Constipation Chronic Idiopathic | Constipation (Excl Faecal Impaction)United States
-
Pamukkale UniversityRecruiting
-
Shanghai University of Traditional Chinese MedicineLonghua Hospital; Shanghai Municipal Hospital of Traditional Chinese MedicineRecruiting
-
Universidade Nova de LisboaCINTESIS - Center for Health Technology and Services ResearchRecruiting
Clinical Trials on acupuncture
-
Federal University of São PauloCompleted
-
University of ZurichCharite University, Berlin, Germany; First Teaching Hospital of Tianjin University...CompletedExperimental Dental PainSwitzerland
-
University of SkövdeCompleted
-
National Research Centre of Complementary and Alternative...Norwegian Acupuncture CollegeUnknown
-
Chengdu University of Traditional Chinese MedicineChongqing Medical University; Hunan University of Traditional Chinese MedicineCompletedFunctional Dyspepsia | Postprandial Distress SyndromeChina
-
Chang Gung Memorial HospitalRecruitingIntracranial HemorrhagesTaiwan
-
University of MichiganMassachusetts General Hospital; National Center for Complementary and Integrative...Completed
-
University Medicine GreifswaldRecruitingGagging During Transesophageal EchocardiographyGermany
-
Huazhong University of Science and TechnologyThe University of Hong Kong; Heilongjiang University of Chinese Medicine; Hubei...CompletedPolycystic Ovary SyndromeChina
-
China Medical University HospitalNot yet recruiting